The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Healthcare & Insurance

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution 

GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercializationFirst GE Healthcare FlexFactory™ for cell therapy installation in the world expected to provide CBMG with scalable, fully-equipped cell therapy manufacturing

Saturday, January 20, 2018

Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018

Company announcement - No. 4/2018 Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018                Zealand receives FDA approval of its Investigational New Drug (IND) application for

Friday, January 19, 2018

Brown & Brown, Inc. Announces Quarterly Cash Dividend

DAYTONA BEACH, Fla., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE:BRO) today announced that the Board of Directors has declared a regular quarterly cash dividend of $0.15 per share. The dividend is payable on February 14, 2018 to shareholders of record on February 2, 2018.

Friday, January 19, 2018

Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018

CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its first quarter fiscal 2018 operating results before the NASDAQ market opens on Thursday, January 25, 2018. The release will be

Friday, January 19, 2018

TiGenix: Transparency Information

PRESS RELEASEREGULATED INFORMATION Transparency Information Leuven (BELGIUM) - January 19, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 of the Belgian Law of May 2, 2007 regarding the publication of major

Friday, January 19, 2018

Tonix Pharmaceuticals Announces Publication Reporting Synthesis, Construction and Characterization of a Potential Smallpox-Preventing Vaccine

NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, today announced the publication of research describing the successful synthesis

Friday, January 19, 2018

CorVel Announces Quarterly Earnings Release Webcast

IRVINE, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- In conjunction with CorVel Corporation’s (NASDAQ:CRVL) quarterly earnings release, CorVel will stream a webcast over the Internet on Tuesday, January 30th at 11:30 am Eastern Time. Event: CorVel Corporation Quarterly Earnings

Friday, January 19, 2018

Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee

Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee Paris, France - January 19, 2018 - Sanofi  has appointed Dominique Carouge as Executive Vice President

Friday, January 19, 2018

Tyme Announces Positive Efficacy Data for SM-88 in Pancreatic Cancer at 2018 ASCO Gastrointestinal Cancers Symposium

40 percent of evaluable patients achieved survival of more than 12 months, 30 percent achieved a complete or partial tumor responseAll patients improved or maintained quality of life measures and pain scores SAN FRANCISCO, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq:TYME),

Friday, January 19, 2018

TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma Patients

Two Partial Responses (25%) by RECIST and Three > 50% Reductions of Alpha Fetoprotein in Eight Evaluable Patients (38%) Treated to Date with Combination of TRC105 and Nexavar®   Data Presented at ASCO 2018 Gastrointestinal Cancers Symposium SAN DIEGO, Jan. 19, 2018 (GLOBE NEWSWIRE) --

Friday, January 19, 2018

Tauriga Sciences Inc. Completes its Purchase of Crypto Currency Groestlcoin

NEW YORK, NY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and

Friday, January 19, 2018

PHM Announces Further Details of Plan of Arrangement


Friday, January 19, 2018

MyoKardia Announces Appointment of Cynthia Ladd as General Counsel

SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced the expansion of its executive committee with

Friday, January 19, 2018

XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa

AUSTIN, Texas, Jan. 19, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that results from an open label extension (OLE) phase of the randomized Phase 2 study evaluating XBiotech’s True Human™ antibody, MABp1, as a treatment for Hidradenitis Suppurativa (HS), will be

Friday, January 19, 2018

Albireo to Receive More than $55 Million(1) in Nondilutive Cash Payments

— Elobixibat approved in Japan for the treatment of chronic constipation — — Albireo innovation leads to world’s first approved ileal bile acid transporter (IBAT) inhibitor — BOSTON, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan

Friday, January 19, 2018

Avinger Granted Continued Listing Decision From Nasdaq

REDWOOD CITY, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that the Company has received formal notification that the Nasdaq Hearings Panel (the “Panel”) has granted

Friday, January 19, 2018

VitalHub Corp. Announces the Acquisition of Clarity Healthcare Solutions

TORONTO, Jan. 19, 2018 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSXV:VHI) (the “Company” or “VitalHub”), is pleased to announce that it has acquired Clarity Healthcare Solutions and other selected assets of Clarity Health Inc. (“Clarity”), such assets having previously represented

Friday, January 19, 2018

AmTrust Financial Services, Inc. Announces Retention of Financial Advisor to Review Proposal by Stone Point Capital, the CEO and the Karfunkel Family

NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- AmTrust Financial Services, Inc. (Nasdaq:AFSI) (“AmTrust”), announced that the special committee of its board of directors has retained Deutsche Bank Securities Inc. as its financial advisor.  The Special Committee, with the assistance of Deutsche

Friday, January 19, 2018

Kraig Biocraft Laboratories Creates First Hybrids in New Research Center

ANN ARBOR, Mich., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company succeeded in creating a new hybrid transgenic silkworm at its Michigan production facility. 

Friday, January 19, 2018

Saniona AB: Bulletin from the extraordinary shareholders' meeting on January 19, 2018 in Saniona AB

PRESS RELEASE January 19, 2018 Today, on January 19, 2018, an extraordinary shareholders' meeting was held in Saniona AB (publ). A summary of the resolutions adopted follows below. All resolutions were adopted with the required majority of votes. Election of board members and remuneration for

Friday, January 19, 2018


© 2018 Stock News Now